Columbus, Ohio-based Mettler-Toledo International Inc. (MTD) manufactures and supplies precision instruments and services in the Americas and internationally. With a market cap of $24.6 billion, the company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations.

MTD is scheduled to report its Q2 earnings on Thursday, July 31, after the market closes. Ahead of this event, analysts expect the company to report a profit of $9.58 per share, down marginally from $9.65 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in each of the past four quarters, which is impressive.

For fiscal 2025, analysts expect MTD to report an EPS of $41.55, up 1.1% year over year from $41.11 in fiscal 2024. Moreover, in FY2026, the company’s EPS is expected to rise 10.9% annually to $46.08. 

MTD stock has declined 12.5% over the past 52 weeks, underperforming the S&P 500 Index's ($SPX) 12.7% gain and the Health Care Select Sector SPDR Fund’s (XLV) 11.8% decline over the same time frame.

On May 1, MTD stock declined 1.3% following the release of its Q1 earnings. The company reported revenue of $883.7 million for the period, surpassing Street forecasts. Moreover, its adjusted EPS came in at $8.19, surpassing the consensus estimates by 3.7%. Looking ahead, MTD expects its EPS to range from $9.45 to $9.70 for the quarter that ended in June.

Wall Street analysts are moderately bullish about MTD’s stock, with a "Moderate Buy" rating overall. Among 12 analysts covering the stock, five suggest a “Strong Buy” and seven recommend a “Hold.” MTD’s average analyst price target of $1,300.82 indicates a potential upside of 7.9% from the current levels.